Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Leventhal

Showing results (51-60 of 104) with videos related to

Pageof 11
Sort By:
Arteriosclerosis, Thrombosis, and Vascular Biology|August 2, 2008
Acid sphingomyelinase promotes lipoprotein retention within early atheromata and accelerates lesion progressionCecilia M Devlin, Andrew R Leventhal, George Kuriakose, et al.
Clinical Journal of the American Society of Nephrology : CJASN|January 28, 2012
Long-term kidney allograft function and survival in prednisone-free regimens: tacrolimus/mycophenolate mofetil versus tacrolimus/sirolimusDarshika Chhabra, Anton I Skaro, Joseph R Leventhal, et al.
Clinical Transplantation|June 1, 1994
Steroid-related complications in the cyclosporine eraJ P Fryer, D K Granger, J R Leventhal, et al.
Transplantation|March 10, 1999
Mycophenolate mofetil and tacrolimus as primary maintenance immunosuppression in simultaneous pancreas-kidney transplantation: initial experience in 50 consecutive casesD B Kaufman, J R Leventhal, J Stuart, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|September 16, 2005
Alemtuzumab induction and prednisone-free maintenance immunotherapy in kidney transplantation: comparison with basiliximab induction--long-term resultsDixon B Kaufman, Joseph R Leventhal, David Axelrod, et al.
The Journal of Surgical Research|July 1, 1995
Antibody removal by column immunoabsorption prevents tissue injury in an ex vivo model of pig-to-human xenograft hyperacute rejectionT J Kroshus, A P Dalmasso, J R Leventhal, et al.
Plos One|July 30, 2011
Requirement of cognate CD4+ T-cell recognition for the regulation of allospecific CTL by human CD4+ CD127- CD25+ FOXP3+ cells generated in MLRYuming Yu, Joshua Miller, Joseph R Leventhal, et al.
Human Immunology|December 14, 2011
Favorable effects of alemtuzumab on allospecific regulatory T-cell generationJosh Levitsky, Joseph R Leventhal, Joshua Miller, et al.
Xenotransplantation|April 22, 2004
Evidence that tilapia islets do not express alpha-(1,3)gal: implications for islet xenotransplantationJoseph R Leventhal, JingDong Sun, Jenny Zhang, et al.
Human Immunology|February 7, 2018
Updated follow-up of a tolerance protocol in HLA-identical renal transplant pairs given donor hematopoietic stem cellsJoseph R Leventhal, Joshua Miller, James M Mathew, et al.
Pageof 11

Showing results (51-60 of 104) with videos related to

Sort By:
Pageof 11
Arteriosclerosis, Thrombosis, and Vascular Biology|August 2, 2008
Acid sphingomyelinase promotes lipoprotein retention within early atheromata and accelerates lesion progressionCecilia M Devlin, Andrew R Leventhal, George Kuriakose, et al.
Clinical Journal of the American Society of Nephrology : CJASN|January 28, 2012
Long-term kidney allograft function and survival in prednisone-free regimens: tacrolimus/mycophenolate mofetil versus tacrolimus/sirolimusDarshika Chhabra, Anton I Skaro, Joseph R Leventhal, et al.
Clinical Transplantation|June 1, 1994
Steroid-related complications in the cyclosporine eraJ P Fryer, D K Granger, J R Leventhal, et al.
Transplantation|March 10, 1999
Mycophenolate mofetil and tacrolimus as primary maintenance immunosuppression in simultaneous pancreas-kidney transplantation: initial experience in 50 consecutive casesD B Kaufman, J R Leventhal, J Stuart, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|September 16, 2005
Alemtuzumab induction and prednisone-free maintenance immunotherapy in kidney transplantation: comparison with basiliximab induction--long-term resultsDixon B Kaufman, Joseph R Leventhal, David Axelrod, et al.
The Journal of Surgical Research|July 1, 1995
Antibody removal by column immunoabsorption prevents tissue injury in an ex vivo model of pig-to-human xenograft hyperacute rejectionT J Kroshus, A P Dalmasso, J R Leventhal, et al.
Plos One|July 30, 2011
Requirement of cognate CD4+ T-cell recognition for the regulation of allospecific CTL by human CD4+ CD127- CD25+ FOXP3+ cells generated in MLRYuming Yu, Joshua Miller, Joseph R Leventhal, et al.
Human Immunology|December 14, 2011
Favorable effects of alemtuzumab on allospecific regulatory T-cell generationJosh Levitsky, Joseph R Leventhal, Joshua Miller, et al.
Xenotransplantation|April 22, 2004
Evidence that tilapia islets do not express alpha-(1,3)gal: implications for islet xenotransplantationJoseph R Leventhal, JingDong Sun, Jenny Zhang, et al.
Human Immunology|February 7, 2018
Updated follow-up of a tolerance protocol in HLA-identical renal transplant pairs given donor hematopoietic stem cellsJoseph R Leventhal, Joshua Miller, James M Mathew, et al.
Pageof 11